Jinyu Bio-technology Co., Ltd. (SHA:600201)
China
· Delayed Price · Currency is CNY 14.03
+0.45 (3.31%)
Apr 29, 2026, 3:00 PM CST
Jinyu Bio-technology Revenue
Jinyu Bio-technology had revenue of 346.46M CNY in the quarter ending March 31, 2026, with 21.71% growth. This brings the company's revenue in the last twelve months to 1.33B, down -1.70% year-over-year. In the year 2024, Jinyu Bio-technology had annual revenue of 1.26B, down -21.45%.
Revenue (ttm)
1.33B
Revenue Growth
-1.70%
P/S Ratio
11.18
Revenue / Employee
762.68K
Employees
1,740
Market Cap
14.84B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.26B | -342.77M | -21.45% |
| Dec 31, 2023 | 1.60B | 69.56M | 4.55% |
| Dec 31, 2022 | 1.53B | -247.65M | -13.94% |
| Dec 31, 2021 | 1.78B | 194.41M | 12.29% |
| Dec 31, 2020 | 1.58B | 455.12M | 40.39% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Anhui Anke Biotechnology (Group) | 2.56B |
| Mabwell (Shanghai) Bioscience | 662.52M |
| Inner Mongolia Furui Medical Science | 1.60B |
| Chengzhi | 10.87B |
| Staidson (Beijing) BioPharmaceuticals | 203.92M |
| Tibet Cheezheng Tibetan Medicine | 2.42B |
| InventisBio | 37.29M |
| Vcanbio Cell & Gene Engineering Corp., | 1.42B |